Skip to main content
. 2020 Apr 30;9(4):1834–1840. doi: 10.4103/jfmpc.jfmpc_1037_19

Table 1.

Ann Arbor staging system

Stage Defining status
Stage I Restricted to single lymph node region (I) or a single extranodal site (I-E).
Stage II Two or more areas of nodal involvement on the same side of the diaphragm (II) or one or more lymph node regions with an extranodal site (II-E).
Stage III Lymphatic involvement on both sides of the diaphragm (III), possibly with an extranodal site (III-E), the spleen* (III-S), or both (III-SE).
Stage IV Liver, marrow, or other extensive extranodal disease.
Substage
 Substage E Localized, extranodal disease.
 Substage A Absence of systemic signs.
 Substage B Presence of unexplained weight loss (10% in 6 months), and/or unexplained fever, and/or night sweat.

*The spleen is considered nodal